Abstract
BackgroundNon-steroidal anti-inflammatory drugs (NSAIDs) are regarded as the cornerstone of conventional therapy in ankylosing spondylitis (AS). TNF-α blocking therapy is available for AS patients who have insufficient response to conventional...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have